» Authors » Goran Engberg

Goran Engberg

Explore the profile of Goran Engberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 1524
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahlberg Weidenfors J, Griska V, Li X, Pranckeviciene A, Pakalniene J, Atlas A, et al.
Brain Behav Immun . 2025 Feb; 125:452-465. PMID: 39904470
Background: Tick-borne encephalitis (TBE) patients frequently suffer cognitive and neuropsychiatric sequelae, which may be severe and long-lasting. The underlying mechanisms remain poorly understood, but likely involve dysregulation of immunological and...
2.
Li X, Eden A, Malwade S, Cunningham J, Bergquist J, Ahlberg Weidenfors J, et al.
Brain Behav Immun . 2024 Nov; 124():163-176. PMID: 39615604
Long-term symptoms such as pain, fatigue, and cognitive impairments are commonly observed in individuals affected by coronavirus disease 2019 (COVID-19). Metabolites of the kynurenine pathway have been proposed to account...
3.
Weitzberg E, Ingelman-Sundberg M, Lundberg J, Engberg G, Schulte G, Lauschke V
Pharmacol Rev . 2024 Oct; 76(6):1089-1101. PMID: 39414365
Karolinska Institutet is a medical university encompassing 21 departments distributed across three departmental or campus groups. Pharmacological research has a long and successful tradition at the institute with a multitude...
4.
Orhan F, Schwieler L, Engberg G, Samuelsson M
Int J Tryptophan Res . 2024 Apr; 17:11786469241245323. PMID: 38665132
In recent years, kynurenine metabolites generated by tryptophan catabolism have gained increasing attention in the context of brain diseases. The question of importance is whether there is a relationship between...
5.
Haroon H, Ho A, Gupta V, Dasari S, Sellgren C, Cervenka S, et al.
J Psychiatr Res . 2024 Feb; 171:306-315. PMID: 38340697
Apart from their diagnostic, monitoring, or prognostic utility in clinical settings, molecular biomarkers may be instrumental in understanding the pathophysiology of psychiatric disorders, including schizophrenia. Using untargeted metabolomics, we recently...
6.
Pils M, Rutsch J, Eren F, Engberg G, Piehl F, Cervenka S, et al.
Psychiatry Clin Neurosci . 2023 Sep; 77(12):665-671. PMID: 37668563
Aim: The disrupted-in-schizophrenia 1 (DISC1) protein is a key regulator at the intersection of major signaling pathways relevant for adaptive behavior. It is prone to posttranslational changes such as misassembly...
7.
Eren F, Schwieler L, Orhan F, Malmqvist A, Piehl F, Cervenka S, et al.
Brain Behav Immun . 2023 Aug; 114:163-164. PMID: 37595878
No abstract available.
8.
Zheng Y, Tufvesson-Alm M, Trepci A, Imbeault S, Li X, Schwieler L, et al.
Acta Neuropsychiatr . 2023 Aug; :1-13. PMID: 37592805
Objective: We previously reported that dual injections of lipopolysaccharide (LPS) in mice constitute a valuable tool for investigating the contribution of inflammation to psychotic disorders. The present study investigated how...
9.
Orhan F, Goiny M, Becklen M, Mathe L, Piehl F, Schwieler L, et al.
Schizophr Res . 2023 Jun; 257:34-40. PMID: 37271040
Background: The hypothesis of dopamine dysfunction in psychosis has evolved since the mid-twentieth century. However, clinical support from biochemical analysis of the transmitter in patients is still missing. The present...
10.
Eren F, Schwieler L, Orhan F, Malmqvist A, Piehl F, Cervenka S, et al.
Brain Behav Immun . 2023 May; 111:376-385. PMID: 37146654
Background And Hypothesis: Immune activation is suggested to play an important role in psychosis. In this study, a large number of immune-related proteins were analyzed to obtain a more comprehensive...